Table 1. Clinical and pathological characteristics of the patients.

Variables	Patients (n=48)
Sex, F/M	22/26
Age, years (mean ± SD, range)	39.3 ±10.7, 14-62
Macroadenoma (%)	23 (47.9%)
Microadenoma (%)	4 (8.3%)
Giant adenoma (%)	21 (43.8)
PRL (ng/ml) Grades 1a 1b 2a 2b	771.6 (209-5361) 23 2 20 3
Mean follow-up, years (mean ± SD, range)	4.8 ± 1.17, 2.5–7
Long-term follow-up results (%)
Remission	18 (37.5%)
Persistence	16 (33.3%)
Recurrence	14 (29.2%)

F, female; M, male;